PD-1 Blockade Triggers HBV-Specific B-Cell Responses to Unlock New Combination Immunotherapy Directions for HBV-Associated Hepatocellular Carcinoma July 2026 saw the online publication of high-impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results